Amit Mahipal, MBBS

  • 1019 Citations
  • 16 Scopus h-Index
20052019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Amit Mahipal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Pancreatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Cholangiocarcinoma Medicine & Life Sciences
Cell Nucleus Active Transport Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms

Wolin, E., Mita, A., Mahipal, A., Meyer, T., Bendell, J., Nemunaitis, J., Munster, P. N., Paz-Ares, L., Filvaroff, E. H., Li, S., Hege, K., de Haan, H. & Mita, M., Jan 1 2019, In : PloS one. 14, 9, e0221994.

Research output: Contribution to journalArticle

Open Access
Neuroendocrine Tumors
Carcinoid Tumor
signs and symptoms (animals and humans)
Tumors
mouth

Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma

Chakrabarti, S., Tella, S. H., Kommalapati, A., Huffman, B. M., Yadav, S., Riaz, I. B., Goyal, G., Mody, K., Borad, M. J., Cleary, S., Smoot, R. & Mahipal, A., Jan 1 2019, In : Journal of Gastrointestinal Oncology. 10, 3, p. 554-561 8 p.

Research output: Contribution to journalArticle

Survival
Recurrence
Fibrolamellar hepatocellular carcinoma
Cell Death
Phosphotransferases

FGFR2 genomic aberrations: Achilles heel in the management of advanced cholangiocarcinoma

Mahipal, A., Tella, S. H., Kommalapati, A., Anaya, D. & Kim, R., Aug 1 2019, In : Cancer Treatment Reviews. 78, p. 1-7 7 p.

Research output: Contribution to journalReview article

Cholangiocarcinoma
EphA1 Receptor
Genes
Isocitrate Dehydrogenase
Fibroblast Growth Factor Receptors
2 Citations (Scopus)

First-in-human phase 1 dose-escalating trial of G305 in patients with advanced solid tumors expressing NY-ESO-1

Mahipal, A., Ejadi, S., Gnjatic, S., Kim-Schulze, S., Lu, H., ter Meulen, J. H., Kenney, R. & Odunsi, K., Jan 1 2019, In : Cancer Immunology, Immunotherapy.

Research output: Contribution to journalArticle

Neoplasms
Emulsions
Vaccines
T-Lymphocytes
Safety

Immunotherapy in hepatocellular carcinoma: Is there a light at the end of the tunnel?

Mahipal, A., Tella, S. H., Kommalapati, A., Lim, A. & Kim, R., Aug 1 2019, In : Cancers. 11, 8, 1078.

Research output: Contribution to journalReview article

Open Access
Immunotherapy
Hepatocellular Carcinoma
United States Food and Drug Administration
Translational Medical Research
Liver